In the same infection model an anti-CalA antibody reduced A. fumigatus uptake by A549 cells by 50% and, when injected intraperitoneally prior to A. fumigatus infection, increased the survival of the infected mice by 20%, suggesting CalA to be a plausible target for novel therapeutic interventions. Here, LINC00674 is linked to infection.